Catalyst Funds Management Pty LTD Ocular Therapeutix, Inc Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 5,600 shares of OCUL stock, worth $50,288. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,600Holding current value
$50,288% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
172Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$129 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$115 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$114 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$75.3 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $691M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...